GHRP-2 (Growth Hormone-Releasing Peptide-2, also known as Pralmorelin) is a synthetic hexapeptide (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH₂) that acts as a selective agonist of the growth hormone secretagogue receptor (GHS-R). GHRP-2 is generally considered the most potent of the hexapeptide GH secretagogues, producing robust GH release with peak plasma levels approximately 15-30 minutes post-administration.

Compared to GHRP-6, GHRP-2 demonstrates higher potency for GH release while exhibiting less pronounced effects on appetite and prolactin secretion, making it a more selective tool for GH secretion studies. Research has examined GHRP-2's influence on IGF-1 production, body composition parameters, and metabolic rate in preclinical models.

Pure Pharm Peptides' GHRP-2 is verified at 97.825% purity, providing researchers with a potent GH secretagogue for growth hormone axis investigations.

Research Applications:

• High-potency GH secretagogue studies
• GHS-R1a receptor pharmacology research
• Comparative GH secretagogue potency studies (GHRP-2 vs. GHRP-6 vs. Ipamorelin)
• IGF-1 production and downstream GH effects research
• Body composition and metabolic rate investigations
• Synergistic GH release with GHRH analog combinations

Key Specifications:

• Purity: 97.825% verified by third-party testing
• Dosage: 5mg per vial
• Category: Growth Hormone
• Storage: -20°C or colder (lyophilized)
• Stability: Up to 2 years when stored properly

Research Highlights:

• 97.825% purity verified by independent third-party HPLC analysis
• Most potent hexapeptide GH secretagogue — higher potency than GHRP-6
• Less appetite stimulation than GHRP-6 — more selective GH release
• Also known as Pralmorelin — well-characterized in research literature
• Molecular weight: 818.0 Da | CAS: 158861-67-7 | PubChem CID: 6918245